Use of an anti atherothrombotic Compound for the production of Medicines for the treatment of vascular Disorders

摘要

? The use of acid, 3 - [6 - [(4 - chlorine - phenylsulfonyl) amino] - 2 - tetrahidronaft 5,6,7,8] - - i - 1} - il propionic acid of the formula (i) in the form of optical isomer or a pharmaceutically acceptable salts thereof, for the manufacture of a Medicament for the Treatment The Disorder is Sculares in patients with a History of cerebral vascular accident.The use of acid, 3 - [6 - [(4 - chlorine - phenylsulfonyl) amino] - 2 - methyl - 1 - tetrahidronaft 5,6,7,8 - il} propionic acid of the formula (i) in the form of optical isomer or its pharmaceutically acceptable salts of according to claim 1, for obtaining a Medicine designed to reduc The events Go cardio vascular and cerebrovascular patientsWith A History of Stroke.The use of acid, 3 - [6 - [(4 - chlorine - feni] sulfonyl) amino] - 2 - methyl - 1 - tetrahidronaft 5,6,7,8 - il} propionic acid of the formula (i) in the form of optical isomer or its pharmaceutically acceptable salts according to claim 1 or 2,For obtaining a Medicine to reduce cardiovascular and cerebrovascular events in patients with a History of Stroke.The use of acid, 3 - [6 - [(4 - chlorine - phenylsulfonyl) amino] - 2 - methyl - 1 - tetrahidronaft 5,6,7,8 - il} propionic acid of the formula (i) in the form of optical isomer or its pharmaceutically acceptable salts according to claim 1 or 2,For obtaining a Medicine to reduce cardiovascular and cerebrovascular events in patients with a History of Transient ischemic Attack.